Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BMA vs TRMK: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TRMK Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–3 Matrix Metrics)

TRMK Overall Winner 6-Pillar Tally: BMA 2 – 3 TRMK (1 Tie) Matrix Metrics: BMA 3 – 7 TRMK

As of Nov 16, 2026, Trustmark Corp (TRMK) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BMA carries a Unified Composite Score of 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin), whereas TRMK carries 48.3/100 (HOLD) at $47.63 (11.1x Forward P/E, 35.1% operating margin).

  • Technical & Structure Timing Caution: BMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7); meanwhile TRMK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BMA vs TRMK
BMA NYSE
Banco Macro S.A.
Commercial Banks, Nec
$53.85
-5.29% 1D
Market Cap $3.6B
TTM Revenue $3.48B
Forward P/E 3.1x
Beta / 30D Vol 1.42β · 42% Vol
Unified Composite Score
39.3 / 100 SELL
Tech 29.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.8%), weak momentum, RSI 31
RSI-14: 30.7 · SMA20: $59.84 · SMA50: $66.06
TRMK NASDAQ Head-to-Head Winner
Trustmark Corp
National Commercial Banks
$47.63
-0.52% 1D
Market Cap $2.8B
TTM Revenue $819M
Forward P/E 11.1x
Beta / 30D Vol 0.29β · 27% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 51.0 Fund 44.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 62
RSI-14: 61.6 · SMA20: $45.73 · SMA50: $45.68

6-Pillar Scorecard Institutional Category Breakdown (BMA 2 – 3 TRMK)

Columns: Metric · BMA · TRMK
1. Valuation Multiples BMA
Forward P/E 3.1x 11.1x
Trailing P/E 11.6x 12.0x
PEG Ratio 0.47x 2.29x
EV / Revenue 1.0x 3.4x
2. Growth & Scale TRMK
Revenue Growth (YoY) +1.2% +2.1%
Earnings Growth (YoY) +3.5% +6.4%
TTM Revenue (USD) $3.48B $819M
Market Cap $3.6B $2.8B
3. Profitability & Quality TRMK
Gross Margin 98.7% 100.0%
Operating Margin 18.0% 35.1%
Net Profit Margin 9.0% 28.7%
Return on Equity (ROE) 7.1% 11.2%
4. Balance Sheet & Cash Flow TRMK
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage $64.45 Book/Sh · 7.1% ROE $36.21 Book/Sh · 11.2% ROE
Dividend Yield None (0.00%) 2.07%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 77.3% (51st %ile) 174.6% (100th %ile)
Put/Call OI Skew Thin ADR Chain N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat BMA
OpEx & R&D Intensity 80.7% of Rev ($2.81B) 64.9% of Rev ($532M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat High-Margin Pricing Power Moat
Supply-Chain Role Banks - Regional Operator Banks - Regional Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BMA (3) vs TRMK (7)
Institutional Metric BMA TRMK Criterion Row Edge
Market Capitalization
Scale
$3.6B $2.8B Larger Scale BMA
Trailing P/E Ratio
Valuation
11.6x 12.0x Lower Multiple BMA
Forward P/E Ratio
Valuation
3.1x 11.1x Lower Multiple BMA
Revenue Growth (YoY)
Growth
+1.2% +2.1% Higher Growth TRMK
Operating Margin (TTM)
Profitability
18.0% 35.1% Higher Margin TRMK
Net Profit Margin
Profitability
9.0% 28.7% Higher Margin TRMK
Return on Equity (ROE)
Capital Efficiency
7.1% 11.2% Higher ROE TRMK
52-Week Range Position
Momentum
0% ($54–$106) 89% ($36–$49) Stronger Trend TRMK
Beta / 30D Volatility
Risk Regime
1.42β · 42% Vol 0.29β · 27% Vol Lower Realized Risk TRMK
Unified Institutional Score
Composite Signal
39.3 / 100 (SELL) 48.3 / 100 (HOLD) Higher Composite TRMK
Trailing 12M Revenue (USD)
Operating Scale
$3.48B $819M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
98.7% 100.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.47x PEG · 1.0x EV/Rev 2.29x PEG · 3.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($64.45 Book/Sh · 7.1% ROE) N/A ($36.21 Book/Sh · 11.2% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TRMK +21.99 pp
BMA: -15.91% · TRMK: +6.08%
3M Horizon TRMK +29.09 pp
BMA: -29.22% · TRMK: -0.13%
6M Horizon TRMK +34.28 pp
BMA: -25.81% · TRMK: +8.47%
1Y Horizon TRMK +60.02 pp
BMA: -35.24% · TRMK: +24.78%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BMA vs TRMK. Trailing 12-month operating profitability (BMA 18.0% vs TRMK 35.1%) and valuation multiples (BMA 3.1x vs TRMK 11.1x Forward P/E) are benchmarked directly in Pillar 4 below.

BMA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$3.48B
Gross Margin98.7%
Op. Margin18.0%
ROE / Fwd P/E7.1% · 3.1x
TRMK ADR TTM Benchmark FX-Normalized USD
TTM Revenue$819M
Gross Margin100.0%
Op. Margin35.1%
ROE / Fwd P/E11.2% · 11.1x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BMA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 77.3%
IV Percentile 51st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BMA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TRMK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 174.6%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TRMK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BMA Moat Profile Scale & Operating Efficiency Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $3.6B market capitalization and 18.0% operating margin.
OpEx & R&D Reinvestment 80.7% of Rev ($2.81B)
90D Engineering Disclosures 0 Published
TRMK Moat Profile High-Margin Pricing Power Moat
Banks - Regional Operator
Competes within the Banks - Regional value chain with $2.8B market capitalization and 35.1% operating margin.
OpEx & R&D Reinvestment 64.9% of Rev ($532M)
90D Engineering Disclosures 0 Published

Investor FAQ BMA vs TRMK Key Questions & Quantitative Answers

As of Nov 16, 2026, Trustmark Corp (TRMK) is the stronger overall head-to-head candidate over Banco Macro S.A. (BMA) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). BMA carries a Unified Composite Score of 39.3/100 (SELL) at $53.85 (3.1x Forward P/E, 18.0% operating margin), whereas TRMK carries 48.3/100 (HOLD) at $47.63 (11.1x Forward P/E, 35.1% operating margin). Technical & Structure Timing Caution: BMA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 30.7); meanwhile TRMK trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 61.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

TRMK leads the Growth & Scale pillar: BMA posts +1.2% YoY revenue growth and +3.5% YoY earnings growth on $3.48B TTM revenue (98.7% gross margin, 18.0% operating margin), compared with TRMK at +2.1% YoY revenue growth and +6.4% YoY earnings growth on $819M TTM revenue (100.0% gross margin, 35.1% operating margin). On trailing 12-month operating scale, BMA generates $3.48B in USD-normalized revenue versus $819M for TRMK. In operating R&D and SG&A reinvestment, BMA deploys 80.7% of Rev ($2.81B) (0 90-day corporate R&D disclosures) versus 64.9% of Rev ($532M) (0 disclosures) for TRMK.

BMA screens cheaper on headline valuation multiples. BMA trades at 3.1x Forward P/E, 11.6x Trailing P/E, 0.47x PEG, and 1.0x EV/Revenue (unreported cash flow margin), whereas TRMK trades at 11.1x Forward P/E, 12.0x Trailing P/E, 2.29x PEG, and 3.4x EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BMA (7.1% ROE) versus TRMK (11.2% ROE) capital efficiency.

In options market volatility and institutional positioning, BMA carries 77.3% implied volatility (51st %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.42β · 42% Vol realized risk). By comparison, TRMK carries 174.6% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.29β · 27% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.